Reply by Authors.

Autor: Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Lobo N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Brooks NA; UPMC Urology of Central Pennsylvania, Harrisburg, Pennsylvania., Nogueras-Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas., Guo CC; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas., Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Grossman HB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Jazyk: angličtina
Zdroj: The Journal of urology [J Urol] 2022 Aug; Vol. 208 (2), pp. 290-291. Date of Electronic Publication: 2022 Jun 30.
DOI: 10.1097/JU.0000000000002678.02
Databáze: MEDLINE